Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INOVIO PHARMACEUTICALS, INC.

(INO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about INOVIO PHARMACEUTICALS, INC.
2017Certain Warrants of Inovio Pharmaceuticals, Inc. are subject to a Lock-Up Agreement End..
CI
2017Certain Common Stock of Inovio Pharmaceuticals, Inc. are subject to a Lock-Up Agreement..
CI
2017Certain Preferred Stock of Inovio Pharmaceuticals, Inc. are subject to a Lock-Up Agreem..
CI
2017Certain Stock Options of Inovio Pharmaceuticals, Inc. are subject to a Lock-Up Agreemen..
CI
2017Certain Restricted Stock Units of Inovio Pharmaceuticals, Inc. are subject to a Lock-Up..
CI
2017Inovio Pharmaceuticals Begins Phase 1b/2 Cancer Efficacy Trial Combining Its T-cell Imm..
GL
2017Inovio Pharmaceuticals, Inc. Begins Phase 1b/2 Cancer Efficacy Trial Combining Its T-ce..
CI
2017INOVIO PHARMACEUTICALS : Positive Zika Vaccine Clinical Study Data Published in New Englan..
PU
2017Inovio's Positive Zika Vaccine Clinical Study Data Published in New England Journal of..
GL
2017Inovio Pharmaceuticals, Inc. Reports on Positive Safety and Immune Response Results fro..
CI
2017Inovio and Partners Initiate Phase 1/2a Clinical Trial To Further Advance Its Vaccine A..
GL
2017Korean Ministry of Food and Drug Safety Approves the Initiation of Inovio Pharmaceutica..
CI
2017Inovio's Cancer Immunotherapy (INO-5150) Slowed PSA Rise and Significantly Increased PS..
GL
2017Inovio Pharmaceuticals, Inc.’s Cancer Immunotherapy (INO-5150) Slows PSA Rise and Signi..
CI
2017Inovio Pharmaceuticals to Participate ináUpcoming Investment Conferences
GL
2017Inovio Pharmaceuticals Reports 2017 Second Quarter Financial Results
GL
2017Inovio Pharmaceuticals, Inc. Reports Unaudited Consolidated Earnings Results for the Se..
CI
2017Inovio Pharmaceuticals to Report Second Quarter 2017 Financial Results on August 8, 201..
GL
2017Inovio Announces Pricing of Public Offering of Common Stock
GL
2017Inovio Announces Proposed Public Offering of Common Stock
GL
2017Inovio's DNA-based Monoclonal Antibody Platform Achieves Further Proof-of-Principle Val..
GL
2017Inovio Announces Leadership Appointments
GL
2017Inovio Pharmaceuticals, Inc. Announces Leadership Appointments
CI
2017Inovio Pharmaceuticals to Participate on Panel at 2017 BIO International Convention
GL
2017Inovio Fully Enrolls 160 Subjects in Puerto Rico for Second Zika Vaccine Phase 1 Trial;..
GL
2017Inovio Pharmaceuticals, Inc. Completes Enrollment of Phase 1 Clinical Trial in Puerto R..
CI
2017INOVIO PHARMACEUTICALS : Begins Phase 3 Clinical Trial of VGX-3100 for the Treatment of HP..
PU
2017Inovio Begins Phase 3 Clinical Trial of VGX-3100 for the Treatment of HPV-Related Cervi..
GL
2017Inovio Begins Phase 3 Clinical Trial of VGX-3100 for the Treatment of HPV-Related Cervi..
CI
2017Inovio Zika Vaccine Prevents Persistence of Virus and Damage in Male Reproductive Tract..
GL
2017Inovio Pharmaceuticals, Inc. Announces Partnership with Genentech to Evaluate Combinati..
CI
2017Inovio Announces Clinical Trial Collaboration to Evaluate a Novel T-cell Immunotherapy ..
GL
2017Inovio HIV Vaccine Elicits Nearly 100% Immune Response Rates in a Clinical Study
GL
2017Inovio Pharmaceuticals, Inc.'s HIV Vaccine Elicits Nearly 100% Immune Response Rates in..
CI
2017Inovio Pharmaceuticals Reports 2017 First Quarter Financial Results
GL
2017Inovio Pharmaceuticals, Inc. Announces Unaudited Consolidated Earnings Results for the ..
CI
2017Inovio Provides Update on MedImmune Launch of Combination Trial for HPV-associated Head..
GL
2017INOVIO PHARMACEUTICALS : Regeneron and Inovio Enter Immuno-Oncology Clinical Study Agreeme..
PR
2017Inovio & Regeneron Enter Immuno-Oncology Clinical Study Agreement for Glioblastoma Comb..
GL
2017Inovio Pharmaceuticals to Participate ináBank of America Merrill Lynch 2017 Healthcare ..
GL
2017Inovio Pharmaceuticals to Report First Quarter 2017 Financial Results May 10, 2017
GL
2017Inovio Initiates Phase 2 Efficacy Trial with VGX-3100 For HPV-Related Vulvar Pre-Cancer..
GL
2017Inovio Pharmaceuticals, Inc. Initiates Phase 2 Efficacy Trial with VGX-3100 for HPV-Rel..
CI
2017INOVIO PHARMACEUTICALS : Research Reports Initiation on Biotech Stocks -- Tesaro, Alnylam ..
PR
2017Inovio Ebola Vaccine Demonstrates Robust Immune Responses with Favorable Safety Profile..
GL
2017Inovio Pharmaceuticals, Inc. Announces Preliminary Results from the Expanded Stage of i..
CI
2017Inovio and Collaborators Receive NIH Grantáto Evaluate HIV Immunotherapy PENNVAX«-GP's ..
GL
2017George Bickerstaff Elected to Inovio's Board of Directors
GL
2017Inovio Pharmaceuticals, Inc. Appoints George Bickerstaff to its Board of Directors
CI
2017INOVIO PHARMACEUTICALS : Reports 2016 Fourth Quarter and Year End Financial Results
PU
2017Inovio Pharmaceuticals Reports 2016 Fourth Quarter and Year End Financial Results
GL
2017Inovio Pharmaceuticals, Inc. Announces Consolidated Earnings Results for the Fourth Qua..
CI
2017Inovio Pharmaceuticals, Inc. Announces Nancy J. Wysenski Not Stand for Re-Election as A..
CI
2017Inovio Pharmaceuticals to Report Fourth Quarter and Year End 2016 Financial Results on ..
GL
2017Inovio's SynCon« WT1 Cancer Antigen Breaks Tolerance, Highlights Potential for Universa..
GL
2017INOVIO PHARMACEUTICALS : Reports New Positive Clinical Data on Vaccine Advances in the Fig..
PU
2017Inovio Reports New Positive Clinical Data on Vaccine Advances in the Fight Against Eme..
GL
2017Inovio Pharmaceuticals, Inc. Reports New Positive Clinical Data on Vaccine Advances in ..
CI
2017Inovio and ApolloBio to Collaborate on Development and Commercialization of HPV Pre-can..
GL
2017Inovio and ApolloBio to Collaborate on Development and Commercialization of HPV Pre-can..
CI
2017Inovio Pharmaceuticals, Inc. announced that it expects to receive $35 million in fundin..
CI
2017Inovio Pharmaceuticals to Participate ináUpcoming Investment Conferences
GL
2016Inovio's Zika VaccineáGenerates Robust Immune Responses in First Human Study
GL
2016Inovio Pharmaceuticals, Inc. Announces Data from Phase I Zika Virus Trial
CI
2016Inovio MERS Vaccine Development to be Expanded with Funding from International Vaccine ..
GL
2016Inovio Pharmaceuticals Awarded $6.1 Million Sub-grant Through Wistar Institute to Devel..
GL
2016Inovio's Co-Founder and Chair of its Scientific Advisory Board Selected as a Top 20 Tra..
GL
2016Inovio Wins Deloitte's “Fast 500” Growth Award
GL
2016Inovio's Cancer Immunotherapy (INO-3112) Generates T Cell Immune Responses in Tumor Tis..
GL
2016Inovio Pharmaceuticals Zika Vaccine Protects Animalsáfrom Infection, Brain Damage and D..
GL
2016Inovio Pharmaceuticals Reports 2016 Third Quarter Financial Results
GL
2016Inovio Pharmaceuticals, Inc. Announces Unaudited Consolidated Earnings Results for the ..
CI
2016Inovio Pharmaceuticals to Participate in Upcoming Investment Conferences
GL
2016Inovio Pharmaceuticals to Report Third Quarter 2016 Financial Results November 9, 2016
GL
2016Inovio Announces FDA Request for Additional Information For Phase III Program; Trial In..
GL
Prev.3  4  5  6  7   8  9  10Next
Upcoming event on INOVIO PHARMACEUTICALS, INC.